CytomX Therapeutics, Inc.

8-K Director or officer change Jul 27, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 22, 2026 8-K Entered a material agreement Jun 3, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Other events Mar 19, 2026 8-K Results of operations (earnings release) Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Other events Aug 13, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 8-K Other events May 28, 2025 8-K Other events May 13, 2025 8-K Results of operations (earnings release); Other events May 12, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) Mar 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 6, 2025 8-K Delisting notice or listing-rule failure Feb 26, 2025 8-K Director or officer change Feb 3, 2025 8-K Exit or disposal costs Jan 6, 2025 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Director or officer change Jun 17, 2024 8-K Amended charter or bylaws; Shareholder vote results May 17, 2024 8-K Other events May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Director or officer change; Amended charter or bylaws Mar 22, 2024 8-K Results of operations (earnings release) Mar 11, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Results of operations (earnings release) Nov 7, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Entered a material agreement Aug 24, 2023 8-K Results of operations (earnings release) Aug 8, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023